Vai al contenuto

Novembre 2023

WHITENEST PHARMA’S BIONEST 2.0 SYSTEM VALIDATES MULTI-COMPONENT CORD BLOOD BANKING, REPORTED IN BLOOD TRANSFUSION JOURNAL

A recent study published in Blood Transfusion (2023; doi: 10.2450/BloodTransfus.492) details the successful validation of WhiteNest Pharma’s BioNest 2.0 system in a multi-component cord blood banking exercise. This international study, involving 12 public cord blood banks from Spain, Italy, Greece,… Leggi tutto »WHITENEST PHARMA’S BIONEST 2.0 SYSTEM VALIDATES MULTI-COMPONENT CORD BLOOD BANKING, REPORTED IN BLOOD TRANSFUSION JOURNAL